Probiotics and prebiotics in Crohn's disease therapies

Best Practice and Research: Clinical Gastroenterology

Volumn 30, Issue 1, 2016, Pages 81-88

  Lichtenstein, Lev ^a,b   Avni Biron, Irit ^a,b   Ben Bassat, Ofer ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bifidobacterium; Crohn's disease; Inflammatory bowel disease; Lactobacillus; Prebiotics; Probiotics; Sacchromyces boullardi; Synbiotics; VSL 3

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM; CROHN DISEASE; ENTEROPATHY; HUMAN; ILEITIS; POSTOPERATIVE PERIOD; RECURRENT DISEASE; REMISSION; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; GASTROINTESTINAL TRACT; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY;

COLITIS, ULCERATIVE; CROHN DISEASE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; PREBIOTICS; PROBIOTICS;

EID: 84962427817     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2016.02.002     Document Type: Review

References (38)

1. N. Arpaia, and et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation Nature 504 7480 2013 451 455
2. Y. Furusawa, Y. Obata, S. Fukuda, T.A. Endo, G. Nakato, D. Takahashi, and et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells Nature 504 7480 2013 446 450
3. J.L. Round, and S.K. Mazmanian Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota Proc Natl Acad Sci U. S. A 107 27 2010 12204 12209
4. I.I. Ivanov, and D.R. Littman Modulation of immune homeostasis by commensal bacteria Curr Opin Microbiol 14 1 2011 106 114
5. E. Bellaguarda, and E.B. Chang IBD and the gut microbiota-from bench to personalized medicine Curr Gastroenterol Rep 17 4 2015 15
6. K. Plein, and J. Hotz Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea-a pilot study Z Gastroenterol 31 2 1993 129 134
7. M. Schultz, A. Timmer, H.H. Herfarth, R.B. Sartor, J.A. Vanderhoof, and H.C. Rath Lactobacillus GG in inducing and maintaining remission of Crohn's disease BMC Gastroenterol 4 2004 5
8. H. Steed, G.T. Macfarlane, K.L. Blackett, B. Bahrami, N. Reynolds, S.V. Walsh, and et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease Aliment Pharmacol Ther 32 7 2010 872 883
9. S. Fujimori, A. Tatsuguchi, K. Gudis, T. Kishida, K. Mitsui, A. Ehara, and et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease J Gastroenterol Hepatol 22 8 2007 1199 1204
10. P. Gupta, H. Andrew, B.S. Kirschner, and S. Guandalini Is lactobacillus GG helpful in children with Crohn's disease? results of a preliminary, open-label study J Pediatr Gastroenterol Nutr 31 4 2000 453 457
11. A.D. Butterworth, A.G. Thomas, and A.K. Akobeng Probiotics for induction of remission in Crohn's disease Cochrane Database Syst Rev 3 2008 CD006634
12. J. Shen, Z.X. Zuo, and A.P. Mao Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials Inflamm Bowel Dis 20 1 2014 21 35
13. Y.A. Ghouri, D.M. Richards, E.F. Rahimi, J.T. Krill, K.A. Jelinek, and A.W. DuPont Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Clin Exp Gastroenterol 7 2014 473 487
14. M. Fujiya, N. Ueno, and Y. Kohgo Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials Clin J Gastroenterol 7 1 2014 1 13
15. D. Jonkers, J. Penders, A. Masclee, and M. Pierik Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients Drugs 72 6 2012 803 823
16. M. Guslandi, G. Mezzi, M. Sorghi, and P.A. Testoni Saccharomyces boulardii in maintenance treatment of Crohn's disease Dig Dis Sci 45 7 2000 1462 1464
17. A. Bourreille, G. Cadiot, G. Le Dreau, D. Laharie, L. Beaugerie, J.L. Dupas, and et al. Saccharomyces boulardii does not prevent relapse of Crohn's disease Clin Gastroenterol Hepatol 11 8 2013 982 987
18. H.A. Malchow Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 25 4 1997 653 658
19. R. Willert, K. Peddi, J. Ombiga, P. Bampton, and I. Lawrance T1235 Randomised, double-blinded, placebo-controlled study of VSL#3 versus placebo in the maintenance of remission in Crohns disease Gastroenterology 138 5 Suppl 1 2010 S-517-S-518
20. M.A. Zocco, L. Zileri Dal Verme, A. Armuzzi, E.C. Nista, A. Papa, and M. Candelli Comparison of Lactobacillus GG and mesalazine in maintaining remission of ulcerative colitis and Crohn's disease Gastroenterology 124 4 Suppl 1 2003 A201
21. A. Bousvaros, S. Guandalini, R.N. Baldassano, C. Botelho, J. Evans, G.D. Ferry, and et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease Inflamm Bowel Dis 11 9 2005 833 839
22. P. Rutgeerts, G. D'Haens, F. Baert, G. Van Assche, I. Aerden, M. Noman, and et al. T130 Randomized placebo controlled trial of pro- and prebiotics (synbiotics cocktail) for maintenance of infliximab induced remission of luminal Crohn's disease (CD) Gastroenterology 126 4 2004 A467-A467
23. V.E. Rolfe, P.J. Fortun, C.J. Hawkey, and F. Bath-Hextall Probiotics for maintenance of remission in Crohn's disease Cochrane Database Syst Rev 4 2006 CD004826
24. R. Rahimi, S. Nikfar, F. Rahimi, B. Elahi, S. Derakhshani, M. Vafaie, and et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig Dis Sci 53 9 2008 2524 2531
25. J. Shen, H.Z. Ran, M.H. Yin, T.X. Zhou, and D.S. Xiao Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease Intern Med J 39 2 2009 103 109
26. M. Campieri, F. Rizzello, A. Venturi, G. Poggioli, F. Ugolini, U. Helwig, and et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrance of Crohn's disease: a randomized controlled study versus mezalamine Gastroenterology 118 4 Suppl 2 2000 A781/A4197
27. R.N. Fedorak, B.G. Feagan, N. Hotte, D. Leddin, L.A. Dieleman, D.M. Petrunia, and et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease Clin Gastroenterol Hepatol 13 5 2015 928 935 e2
28. C. Prantera, M.L. Scribano, G. Falasco, A. Andreoli, and C. Luzi Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG Gut 51 3 2002 405 409
29. P. Marteau, M. Lemann, P. Seksik, D. Laharie, J.F. Colombel, Y. Bouhnik, and et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial Gut 55 6 2006 842 847
30. A. Van Gossum, O. Dewit, E. Louis, G. de Hertogh, F. Baert, F. Fontaine, and et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection Inflamm Bowel Dis 13 2 2007 135 142
31. I. Chermesh, A. Tamir, R. Reshef, Y. Chowers, A. Suissa, D. Katz, and et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease Dig Dis Sci 52 2 2007 385 389
32. G.A. Doherty, G.C. Bennett, S. Patil, A.C. Cheifetz, and A.C. Moss Interventions for prevention of post-operative recurrence of Crohn's disease Cochrane Database Syst Rev 4 2009 CD006873
33. G.A. Doherty, G.C. Bennett, A.S. Cheifetz, and A.C. Moss Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease Aliment Pharmacol Ther 31 8 2010 802 809
34. E.S. van Loo, G. Dijkstra, R.J. Ploeg, and V.B. Nieuwenhuijs Prevention of postoperative recurrence of Crohn's disease J Crohns Colitis 6 6 2012 637 646
35. A. Hafer, S. Kramer, S. Duncker, M. Kruger, M.P. Manns, and S.C. Bischoff Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study BMC Gastroenterol 7 2007 36
36. J.O. Lindsay, K. Whelan, A.J. Stagg, P. Gobin, H.O. Al-Hassi, N. Rayment, and et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease Gut 55 3 2006 348 355
37. M. Joossens, V. De Preter, V. Ballet, K. Verbeke, P. Rutgeerts, and S. Vermeire Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial Gut 61 6 2012 958
38. J.L. Benjamin, C.R. Hedin, A. Koutsoumpas, S.C. Ng, N.E. McCarthy, A.L. Hart, and et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease Gut 60 7 2011 923 929